Ipilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin Diftitox
Clinical trial NCT02009384 · TERMINATED
Trial details
- NCT number
- NCT02009384
- Sponsor
- University of Louisville
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2014-10-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.